# Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

> **NCT01422733** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Virginia**

## Conditions studied

- Hyperandrogenemia
- Obesity
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** dexamethasone
- **DRUG:** Cosyntropin
- **DRUG:** rhCG

## Key facts

- **NCT ID:** NCT01422733
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2018-07-17
- **Final completion:** 2018-07-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study team decided not to pursue this study.
- **Last updated:** 2018-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422733, "Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01422733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*